Related Experiment Video
Updated: Apr 16, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Glycan engagement dictates hydrocephalus induction by serotype 1 reovirus
Jennifer Stencel-Baerenwald, Kerstin Reiss1, Bärbel S Blaum1
1Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.
Unlabelled:
Receptors expressed on the host cell surface adhere viruses to target cells and serve as determinants of viral tropism. Several viruses bind cell surface glycans to facilitate entry, but the contribution of specific glycan moieties to viral disease is incompletely understood. Reovirus provides a tractable experimental model for studies of viral neuropathogenesis. In newborn mice, serotype 1 (T1) reovirus causes hydrocephalus, whereas serotype 3 (T3) reovirus causes encephalitis. T1 and T3 reoviruses engage distinct glycans, suggesting that glycan-binding capacity contributes to these differences in pathogenesis. Using structure-guided mutagenesis, we engineered a mutant T1 reovirus incapable of binding the T1 reovirus-specific glycan receptor, GM2. The mutant virus induced substantially less hydrocephalus than wild-type virus, an effect phenocopied by wild-type virus infection of GM2-deficient mice. In comparison to wild-type virus, yields of mutant virus were diminished in cultured ependymal cells, the cell type that lines the brain ventricles. These findings suggest that GM2 engagement targets reovirus to ependymal cells in mice and illuminate the function of glycan engagement in reovirus serotype-dependent disease.
Importance:
Receptor utilization strongly influences viral disease, often dictating host range and target cell selection. Different reovirus serotypes bind to different glycans, but a precise function for these molecules in pathogenesis is unknown. We used type 1 (T1) reovirus deficient in binding the GM2 glycan and mice lacking GM2 to pinpoint a role for glycan engagement in hydrocephalus caused by T1 reovirus. This work indicates that engagement of a specific glycan can lead to infection of specific cells in the host and consequent disease at that site. Since reovirus is being developed as a vaccine vector and oncolytic agent, understanding reovirus-glycan interactions may allow manipulation of reovirus glycan-binding properties for therapeutic applications.
Insights
Reovirus serotype 1 (T1) uses the GM2 glycan to infect ependymal cells, causing hydrocephalus in mice. Blocking this glycan-virus interaction reduces disease, highlighting glycan engagement
Area of Science:
- Virology
- Neuroscience
- Glycobiology
Background:
- Viral tropism and disease pathogenesis are determined by host cell surface receptors.
- Reovirus serotypes exhibit distinct glycan-binding specificities, influencing their disease outcomes.
- The precise role of specific glycan moieties in viral neuropathogenesis remains unclear.
Purpose of the Study:
- To investigate the role of the GM2 glycan in T1 reovirus-induced hydrocephalus.
- To determine if GM2 engagement targets reovirus to specific cells in the mouse brain.
- To understand how glycan interactions influence reovirus serotype-dependent disease.
Main Methods:
- Structure-guided mutagenesis was used to create a T1 reovirus mutant unable to bind GM2.
- Hydrocephalus was assessed in newborn mice infected with wild-type or mutant T1 reovirus.
- GM2-deficient mice were infected with wild-type T1 reovirus to assess disease in the absence of the receptor.
- Viral yields were measured in cultured ependymal cells.
Main Results:
- Mutant T1 reovirus, unable to bind GM2, induced significantly less hydrocephalus compared to wild-type virus.
- Wild-type T1 reovirus infection of GM2-deficient mice phenocopied the reduced hydrocephalus observed with the mutant virus.
- Mutant virus replication was diminished in cultured ependymal cells, the target cells for hydrocephalus induction.
- GM2 engagement specifically targets T1 reovirus to ependymal cells.
Conclusions:
- GM2 engagement is a critical determinant of T1 reovirus tropism for ependymal cells in mice.
- This glycan-virus interaction directly contributes to the development of hydrocephalus.
- Understanding these glycan-virus interactions is crucial for manipulating reovirus for therapeutic applications, such as vaccine vectors or oncolytic agents.
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Cytomegalovirus Disease

